I bought more today too
ST is anyone's guess....
Although with 2 conferences in the next 2 weeks, plus the anticipated Ropren pricing, plus the BioA BPO results, plus some developments regarding OP, the short-term may actually look OK
Not as if im holding for the short-term anyway :-)